U.S. FDA set to reorganize its food division starting October
May 30 (Reuters) -The U.S. Food and Drug Administration(FDA) said on Thursday it plans to restructure its food division starting in October helping it to oversee human food supply chains and agricultural products more efficiently.
The regulatory body had come under fire over its slow response to the infant formula shortage in 2022.
WHY IT'S IMPORTANT
The FDA said the reorganization will enable it to be more efficient and agile while regulating the industry.
The reorganization will lead to the creation of a unified Human Foods Program (HFP), the adoption of a new model for the FDA's field operations among other changes.
The HFP will take over the roles of the Center for Food Safety and Applied Nutrition and the Office of Food Policy and Response, along with key functions from the Office of Regulatory Affairs, which will be renamed to the Office of Inspections and Investigations.
KEY QUOTE
"This is a distinctive moment for the FDA... We are a step closer to seeing the largest reorganization of the agency in recent history come to life this fall," said FDA Commissioner Robert M. Califf.
CONTEXT
The FDA announced the HFP's establishment last year after being criticizedfor not providing enough resources for its food-related programs in wake of infant formula shortage.
The changes were made in line with the recommendations made in 2022by the Reagan-Udall Foundation, an organization in part funded by the health regulator, that assessed how the agency could shore up its food operations.
The agency, in September last year, appointedJames Jones, an EPA veteran, as its deputy commissioner for human foods, and put him in charge of setting up the human foods program.
Reporting by Puyaan Singh in Bengaluru; Editing by Tasim Zahid
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
